Medicare Enrolled
Dr. Arnold Brizuela, M.D.
Neurology · Arcadia, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Brizuela from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Brizuela?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Brizuela
Dr. Arnold Brizuela is a neurology specialist in Arcadia, CA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Brizuela performed 752 Medicare services across 489 unique beneficiaries.
Between the years covered by Open Payments, Dr. Brizuela received a total of $29,347 from 88 pharmaceutical and/or device companies across 1502 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Brizuela is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 37% volume in CA
$29,347 industry payments
Medicare Practice Summary
Medicare Utilization ↗752
Medicare services
Top 37% in CA for neurology
489
Unique beneficiaries
$135
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~58 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
267 | $108 | $165 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
155 | $61 | $135 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
109 | $86 | $175 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
73 | $407 | $560 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
63 | $132 | $250 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
48 | $129 | $300 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
37 | $254 | $550 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$29,347
Total received (2018-2024)
Avg $4,192/year across 7 years
Top 12% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
88
Companies
1,502
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$29,044 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$303 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,243
2023
$6,934
2022
$6,145
2021
$4,439
2020
$1,922
2019
$1,415
2018
$247
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$1,639
Eisai Inc.
$571
ABBVIE INC.
$551
Novartis Pharmaceuticals Corporation
$505
PFIZER INC.
$504
Alexion Pharmaceuticals, Inc.
$460
Biogen, Inc.
$428
Neurocrine Biosciences, Inc.
$396
Lundbeck LLC
$383
Lilly USA, LLC
$322
ACADIA Pharmaceuticals Inc
$269
MDD US Operations, LLC
$266
Amneal Pharmaceuticals LLC
$189
ARGENX US, INC.
$170
Otsuka America Pharmaceutical, Inc.
$135
Teva Pharmaceuticals USA, Inc.
$132
Alnylam Pharmaceuticals Inc.
$132
Ipsen Biopharmaceuticals, Inc
$130
EMD Serono, Inc.
$122
Mallinckrodt Hospital Products Inc.
$92
TG Therapeutics, Inc.
$91
JAZZ PHARMACEUTICALS INC.
$80
Supernus Pharmaceuticals, Inc.
$78
Amgen Inc.
$70
ANI Pharmaceuticals, Inc.
$70
Neurelis, Inc.
$53
Avadel CNS Pharmaceuticals, LLC
$52
NEUROPACE, INC.
$41
Genentech USA, Inc.
$35
Grifols USA, LLC
$32
SCILEX PHARMACEUTICALS INC.
$27
LivaNova USA, Inc.
$27
Octapharma USA, Inc.
$26
Sumitomo Pharma America, Inc.
$25
MITSUBISHI TANABE PHARMA AMERICA, INC.
$20
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$19
BANNER LIFE SCIENCES, LLC
$19
SK Life Science, Inc.
$19
AstraZeneca Pharmaceuticals LP
$18
Takeda Pharmaceuticals U.S.A., Inc.
$17
CATALYST PHARMACEUTICALS, INC.
$15
BioMarin Pharmaceutical Inc.
$15
Top 3 companies account for 33.5% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$3,568
Biogen, Inc.
$2,227
Alexion Pharmaceuticals, Inc.
$1,777
Novartis Pharmaceuticals Corporation
$1,576
Lilly USA, LLC
$1,566
PFIZER INC.
$1,111
Lundbeck LLC
$950
ACADIA Pharmaceuticals Inc
$948
Neurocrine Biosciences, Inc.
$870
ABBVIE INC.
$866
Teva Pharmaceuticals USA, Inc.
$814
Supernus Pharmaceuticals, Inc.
$755
Amgen Inc.
$684
Eisai Inc.
$679
AbbVie Inc.
$673
Amneal Pharmaceuticals LLC
$636
JAZZ PHARMACEUTICALS INC.
$510
MDD US Operations, LLC
$506
EMD Serono, Inc.
$495
Biohaven Pharmaceutical Holding Company Ltd.
$438
Allergan, Inc.
$418
Otsuka America Pharmaceutical, Inc.
$406
GENZYME CORPORATION
$391
Biohaven Pharmaceuticals, Inc.
$356
ARGENX US, INC.
$302
Alnylam Pharmaceuticals Inc.
$298
Horizon Therapeutics plc
$253
Celgene Corporation
$246
Takeda Pharmaceuticals U.S.A., Inc.
$210
AQUESTIVE THERAPEUTICS, INC.
$209
Almatica Pharma LLC
$207
Allergan Inc.
$205
Corium, LLC
$200
Zyla Life Sciences
$189
Ipsen Biopharmaceuticals, Inc
$186
Abbott Laboratories
$174
Greenwich Biosciences, Inc.
$170
Kyowa Kirin, Inc.
$142
SK Life Science, Inc.
$141
Acorda Therapeutics, Inc
$136
Avanir Pharmaceuticals, Inc.
$135
Sunovion Pharmaceuticals Inc.
$132
Mallinckrodt Hospital Products Inc.
$125
CSL Behring
$124
Zogenix Inc.
$112
Grifols USA, LLC
$111
Boston Scientific Corporation
$110
Octapharma USA, Inc.
$108
Adamas Pharmaceuticals, Inc.
$107
Janssen Pharmaceuticals, Inc
$95
TG Therapeutics, Inc.
$91
Neurelis, Inc.
$90
Zyla Life Sciences, Inc.
$84
Arbor Pharmaceuticals, Inc.
$81
Azurity Pharmaceuticals, Inc.
$78
EISAI INC.
$71
ANI Pharmaceuticals, Inc.
$70
Harmony Biosciences LLC
$69
UPSHER-SMITH LABORATORIES LLC
$63
Ironshore Pharmaceuticals Inc.
$62
MITSUBISHI TANABE PHARMA AMERICA, INC.
$59
IMPEL PHARMACEUTICALS INC.
$56
ARBOR PHARMACEUTICALS, INC.
$55
Genentech USA, Inc.
$55
Avadel CNS Pharmaceuticals, LLC
$52
Marinus Pharmaceuticals, Inc.
$51
ASSERTIO THERAPEUTICS, Inc.
$49
Sumitomo Pharma America, Inc.
$47
Catalyst Pharmaceuticals, Inc.
$41
NEUROPACE, INC.
$41
Merz Pharmaceuticals, LLC
$38
CATALYST PHARMACEUTICALS, INC.
$37
Retrophin, Inc.
$36
Avion Pharmaceuticals
$30
Assertio Therapeutics, Inc.
$30
SCILEX PHARMACEUTICALS INC.
$27
LivaNova USA, Inc.
$27
Medtronic, Inc.
$26
Vanda Pharmaceuticals Inc.
$24
Banner Life Sciences, LLC
$21
Electromed, Inc.
$21
Vertical Pharmaceuticals, LLC
$20
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$19
BANNER LIFE SCIENCES, LLC
$19
AstraZeneca Pharmaceuticals LP
$18
Collegium Pharmaceutical, Inc.
$17
BioMarin Pharmaceutical Inc.
$15
Travere Therapeutics, Inc.
$12
Top 3 companies account for 25.8% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · ADLARITY · ADUHELM · AGAMREE · AIMOVIG · AJOVY · AMVUTTRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aduhelm · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Brineura · Briviact · CAMBIA · CAPLYTA · COMIRNATY · CREXONT · Cambia · Cholbam · DAYBUE · Dhivy · Dysport · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Edarbi · Epidiolex · Eprontia · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GENERAL PAIN MANAGEMENT · GOCOVRI · GRALISE · Gamunex-C · General - DBS · Gocovri · Gralise · HETLIOZ · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · JORNAY PM · KESIMPTA · KISUNLA · KYNMOBI · LEQEMBI · LUMRYZ · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NAPRELAN · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PAXLOVID · POMPE - DISEASE · PURIFIED CORTROPHIN GEL · Ponvory · QALSODY · QULIPTA · Qelbree · RADICAVA · REXULTI · REYVOW · RNS Neurostimulator Kit · RYTARY · Rystiggo · SMARTVEST · SOLIRIS · SPRIX · SUNOSI · SYMPAZAN · Soliris · TOSYMRA · TRINTELLIX · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VANTA ADAPTIVESTIM · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · Wakix · XADAGO · XARELTO · XCOPRI · XYWAV · Xeomin · ZEPOSIA · ZTALMY · ZTLido · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
477
Per 100K population
4.8
County median income
$87,760
Nearest hospital
USC ARCADIA HOSPITAL
1.3 mi
1.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Brizuela is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 12% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Brizuela experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Brizuela performed 267 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Brizuela receive payments from pharmaceutical companies?
Yes. Dr. Brizuela received a total of $29,347 from 88 companies across 1,502 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Brizuela's costs compare to other neurologists in Arcadia?
Dr. Brizuela's average Medicare payment per service is $135. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Brizuela) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Arcadia
Browse neurologists in Arcadia ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology